Welcome to Waikato Clinical Research (2008) Ltd

Waikato Clinical Research (2008) Ltd is a well established clinical trials unit which has continued with the facilities and management staff of Waikato Clinical
Research which was founded in 1978 by Dr Colin Brown.  Waikato Clinical Research has performed a wide range of studies from Phase II to post marketing studies. 
We have also performed medical device post operative studies and numerous pharmacokinetic studies.


Waikato Clinical Research has an excellent and well known international reputation for providing high quality data.  The site was instrumental in the development
program for Ketorolac (Toradol) and studies undertaken by Waikato Clinical Research have had a significant effect on the understanding and management of post
operative pain.

As Waikato Clinical Research is an independent entity our processes in place ensure for the sponsor a quick start-up time, fast recruitment, with realistic time frames.

 
Waikato Clinical Research (2008) Ltd can offer expertise in Phase II, Phase III and Phase IV trials. We can call upon 20 years of experience in conducting acute and chronic analgesic clinical trials, either using a post operative pain model or chronic pain model. We are also experienced in trials in related areas such as relieving opioid induced constipation and nausea and vomiting.
  • Acute and chronic pain trials.
  • Phase II - IV analgesic clinical trials.
  • PONV clinical trials.
  • Antibiotic clinical trials. 
  • Dermatology clinical trials. .
  • Neurology.
  • Renal.
Waikato Clinical Research (2008) Ltd (WCR) is an organisation dedicated to investigating new methods of relieving pain.

Since its beginnings in 1978, over 5000 people have taken part in carefully designed studies to ascertain the effectiveness of pain relieving compounds.